Measuring circulating tumor cell mRNA in peripheral blood samples of patients receiving chemotherapy, researchers found that progression-free and overall survival were worse in those patients whose survivin levels were higher before, after one, and after 3 cycles of chemotherapy [18]. The gene discussed is BIRC5; the disease is neoplasm.